Selected research
Industry Research
Weight Loss and Obesity Management Industry Research Report 2026
Market perspective
The global Weight Loss and Obesity Management market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Weight Loss and Obesity Management market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Weight Loss and Obesity Management market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Weight Loss and Obesity Management market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Weight Loss and Obesity Management include Eisai, Johnson & Johnson, Novo Nordisk, Medtronic, Roche, GlaxoSmithKline, Vivus Inc, ReShape Lifesciences and Obalon Therapeutics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Weight Loss and Obesity Management market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Weight Loss and Obesity Management.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Weight Loss and Obesity Management Market by Company
Eisai
Johnson & Johnson
Novo Nordisk
Medtronic
Roche
GlaxoSmithKline
Vivus Inc
ReShape Lifesciences
Obalon Therapeutics
Nalpropion Pharmaceuticals
Beijing Noble Laser Technology
Allurion Technologies
Allergan
Weight Loss and Obesity Management Segment by Type
Weight Loss and Obesity Management Devices
Weight Loss and Obesity Management Drugs
Weight Loss and Obesity Management Segment by Application
Men
Women
Weight Loss and Obesity Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight Loss and Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Weight Loss and Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight Loss and Obesity Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Weight Loss and Obesity Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Weight Loss and Obesity Management Devices
- Weight Loss and Obesity Management Drugs
Applications
- Men
- Women
Companies covered
- Eisai
- Johnson & Johnson
- Novo Nordisk
- Medtronic
- Roche
- GlaxoSmithKline
- Vivus Inc
- ReShape Lifesciences
- Obalon Therapeutics
- Nalpropion Pharmaceuticals
- Beijing Noble Laser Technology
- Allurion Technologies
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Weight Loss and Obesity Management by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Weight Loss and Obesity Management Devices
- 2.2.3 Weight Loss and Obesity Management Drugs
- 2.3 Weight Loss and Obesity Management by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Men
- 2.3.3 Women
- 2.4 Assumptions and Limitations
3 Weight Loss and Obesity Management Breakdown Data by Type
- 3.1 Global Weight Loss and Obesity Management Historic Market Size by Type (2021-2026)
- 3.2 Global Weight Loss and Obesity Management Forecasted Market Size by Type (2027-2032)
4 Weight Loss and Obesity Management Breakdown Data by Application
- 4.1 Global Weight Loss and Obesity Management Historic Market Size by Application (2021-2026)
- 4.2 Global Weight Loss and Obesity Management Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Weight Loss and Obesity Management Market Perspective (2021-2032)
- 5.2 Global Weight Loss and Obesity Management Growth Trends by Region
- 5.2.1 Global Weight Loss and Obesity Management Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Weight Loss and Obesity Management Historic Market Size by Region (2021-2026)
- 5.2.3 Weight Loss and Obesity Management Forecasted Market Size by Region (2027-2032)
- 5.3 Weight Loss and Obesity Management Market Dynamics
- 5.3.1 Weight Loss and Obesity Management Industry Trends
- 5.3.2 Weight Loss and Obesity Management Market Drivers
- 5.3.3 Weight Loss and Obesity Management Market Challenges
- 5.3.4 Weight Loss and Obesity Management Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Weight Loss and Obesity Management Players by Revenue
- 6.1.1 Global Top Weight Loss and Obesity Management Players by Revenue (2021-2026)
- 6.1.2 Global Weight Loss and Obesity Management Revenue Market Share by Players (2021-2026)
- 6.2 Global Weight Loss and Obesity Management Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Weight Loss and Obesity Management Head Office and Area Served
- 6.4 Global Weight Loss and Obesity Management Players, Product Type & Application
- 6.5 Global Weight Loss and Obesity Management Manufacturers Established Date
- 6.6 Global Weight Loss and Obesity Management Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Weight Loss and Obesity Management Market Size (2021-2032)
- 7.2 North America Weight Loss and Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Weight Loss and Obesity Management Market Size by Country (2021-2026)
- 7.4 North America Weight Loss and Obesity Management Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Weight Loss and Obesity Management Market Size (2021-2032)
- 8.2 Europe Weight Loss and Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Weight Loss and Obesity Management Market Size by Country (2021-2026)
- 8.4 Europe Weight Loss and Obesity Management Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Weight Loss and Obesity Management Market Size (2021-2032)
- 9.2 Asia-Pacific Weight Loss and Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Weight Loss and Obesity Management Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Weight Loss and Obesity Management Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Weight Loss and Obesity Management Market Size (2021-2032)
- 10.2 South America Weight Loss and Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Weight Loss and Obesity Management Market Size by Country (2021-2026)
- 10.4 South America Weight Loss and Obesity Management Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Weight Loss and Obesity Management Market Size (2021-2032)
- 11.2 Middle East & Africa Weight Loss and Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Weight Loss and Obesity Management Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Weight Loss and Obesity Management Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eisai
- 12.1.1 Eisai Company Information
- 12.1.2 Eisai Business Overview
- 12.1.3 Eisai Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.1.4 Eisai Weight Loss and Obesity Management Product Portfolio
- 12.1.5 Eisai Recent Developments
- 12.2 Johnson & Johnson
- 12.2.1 Johnson & Johnson Company Information
- 12.2.2 Johnson & Johnson Business Overview
- 12.2.3 Johnson & Johnson Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.2.4 Johnson & Johnson Weight Loss and Obesity Management Product Portfolio
- 12.2.5 Johnson & Johnson Recent Developments
- 12.3 Novo Nordisk
- 12.3.1 Novo Nordisk Company Information
- 12.3.2 Novo Nordisk Business Overview
- 12.3.3 Novo Nordisk Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.3.4 Novo Nordisk Weight Loss and Obesity Management Product Portfolio
- 12.3.5 Novo Nordisk Recent Developments
- 12.4 Medtronic
- 12.4.1 Medtronic Company Information
- 12.4.2 Medtronic Business Overview
- 12.4.3 Medtronic Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.4.4 Medtronic Weight Loss and Obesity Management Product Portfolio
- 12.4.5 Medtronic Recent Developments
- 12.5 Roche
- 12.5.1 Roche Company Information
- 12.5.2 Roche Business Overview
- 12.5.3 Roche Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.5.4 Roche Weight Loss and Obesity Management Product Portfolio
- 12.5.5 Roche Recent Developments
- 12.6 GlaxoSmithKline
- 12.6.1 GlaxoSmithKline Company Information
- 12.6.2 GlaxoSmithKline Business Overview
- 12.6.3 GlaxoSmithKline Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.6.4 GlaxoSmithKline Weight Loss and Obesity Management Product Portfolio
- 12.6.5 GlaxoSmithKline Recent Developments
- 12.7 Vivus Inc
- 12.7.1 Vivus Inc Company Information
- 12.7.2 Vivus Inc Business Overview
- 12.7.3 Vivus Inc Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.7.4 Vivus Inc Weight Loss and Obesity Management Product Portfolio
- 12.7.5 Vivus Inc Recent Developments
- 12.8 ReShape Lifesciences
- 12.8.1 ReShape Lifesciences Company Information
- 12.8.2 ReShape Lifesciences Business Overview
- 12.8.3 ReShape Lifesciences Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.8.4 ReShape Lifesciences Weight Loss and Obesity Management Product Portfolio
- 12.8.5 ReShape Lifesciences Recent Developments
- 12.9 Obalon Therapeutics
- 12.9.1 Obalon Therapeutics Company Information
- 12.9.2 Obalon Therapeutics Business Overview
- 12.9.3 Obalon Therapeutics Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.9.4 Obalon Therapeutics Weight Loss and Obesity Management Product Portfolio
- 12.9.5 Obalon Therapeutics Recent Developments
- 12.10 Nalpropion Pharmaceuticals
- 12.10.1 Nalpropion Pharmaceuticals Company Information
- 12.10.2 Nalpropion Pharmaceuticals Business Overview
- 12.10.3 Nalpropion Pharmaceuticals Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.10.4 Nalpropion Pharmaceuticals Weight Loss and Obesity Management Product Portfolio
- 12.10.5 Nalpropion Pharmaceuticals Recent Developments
- 12.11 Beijing Noble Laser Technology
- 12.11.1 Beijing Noble Laser Technology Company Information
- 12.11.2 Beijing Noble Laser Technology Business Overview
- 12.11.3 Beijing Noble Laser Technology Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.11.4 Beijing Noble Laser Technology Weight Loss and Obesity Management Product Portfolio
- 12.11.5 Beijing Noble Laser Technology Recent Developments
- 12.12 Allurion Technologies
- 12.12.1 Allurion Technologies Company Information
- 12.12.2 Allurion Technologies Business Overview
- 12.12.3 Allurion Technologies Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.12.4 Allurion Technologies Weight Loss and Obesity Management Product Portfolio
- 12.12.5 Allurion Technologies Recent Developments
- 12.13 Allergan
- 12.13.1 Allergan Company Information
- 12.13.2 Allergan Business Overview
- 12.13.3 Allergan Revenue in Weight Loss and Obesity Management Business (2021-2026)
- 12.13.4 Allergan Weight Loss and Obesity Management Product Portfolio
- 12.13.5 Allergan Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst